Doo-Han Yoo
Overview
Explore the profile of Doo-Han Yoo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
82
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nam Y, Kim S, Park Y, Kim B, Shin S, Leem S, et al.
Aging Cell
. 2024 Jul;
23(9):e14231.
PMID: 38952076
Alzheimer's disease (AD) is a neurodegenerative disorder associated with behavioral and cognitive impairments. Unfortunately, the drugs the Food and Drug Administration currently approved for AD have shown low effectiveness in...
2.
Park H, Kim B, Leem S, Park Y, Chung H, Yoo D, et al.
Curr Med Chem
. 2024 Mar;
PMID: 38486385
Background: Traditional Oriental Medicines (TOMs) formulated using a variety of medicinal plants have a low risk of side effects. In previous studies, five TOMs, namely Dangguijakyaksan, Hwanglyeonhaedoktang, Ukgansan, Palmijihwanghwan, and...
3.
Kim S, Shin S, Nam Y, Park Y, Kim B, Park H, et al.
Int J Biol Macromol
. 2024 Feb;
263(Pt 2):130516.
PMID: 38423419
Tau is a microtubule-associated protein that plays a critical role in the stabilization and modulation of neuronal axons. Tau pathology is stronger associated with cognitive decline in patients with Alzheimer's...
4.
Lim Y, Lee J, Kim S, Cha T, Yoo D, Kim H
Hong Kong J Occup Ther
. 2022 Dec;
35(2):180-189.
PMID: 36467523
Cooperation among rehabilitation team members is essential in the home-based rehabilitation setting. Q-methodology that can quantitatively analyze the subjectivity of members of the rehabilitation team was used to explore the...
5.
Ham M, Kim S, Jo Y, Park C, Nam Y, Yoo D, et al.
Biomedicines
. 2021 Dec;
9(12).
PMID: 34944768
Non-pharmacological intervention, which includes a broad range of approaches, may be an alternative treatment for Alzheimer's disease (AD). Multimodal non-pharmacological intervention alleviates cognitive dysfunction and the impairment of activities of...
6.
Kim S, Nam Y, Ham M, Park C, Moon M, Yoo D
Front Aging Neurosci
. 2021 Aug;
13:682308.
PMID: 34335229
Alzheimer's disease (AD) is an irreversible neurodegenerative brain disorder with aggregation of amyloid-beta (Aβ) and tau as the pathological hallmarks. AD is the most common form of dementia and is...
7.
Nam Y, Shin S, Park Y, Kim M, Jeon S, Lee H, et al.
Antioxidants (Basel)
. 2021 Feb;
10(2).
PMID: 33535469
Alzheimer's disease (AD) is a devastating neurodegenerative disease characterized by irreversible cognitive dysfunction. Amyloid beta (Aβ) peptide is an important pathological factor that triggers the progression of AD through accumulation...
8.
Lim Y, Kim S, Yoo D, Kim H
Assist Technol
. 2020 Jul;
34(3):273-280.
PMID: 32631141
Purpose: The purpose of this study was to investigate the effect of assistive technology-based occupational therapy on occupational performance, satisfaction, and psychosocial impacts of community-dwelling people recovering from stroke. Methods:...
9.
Park S, Bak A, Kim S, Nam Y, Kim H, Yoo D, et al.
Biomedicines
. 2020 Jun;
8(6).
PMID: 32498454
Patients with dementia suffer from psychological symptoms such as depression, agitation, and aggression. One purpose of dementia intervention is to manage patients' inappropriate behaviors and psychological symptoms while taking into...
10.
Kim S, Nam Y, Kim C, Lee H, Hong S, Kim H, et al.
Int J Mol Sci
. 2020 May;
21(10).
PMID: 32456197
Alzheimer's disease (AD) is the most common cause of dementia. The neuropathological features of AD include amyloid-β (Aβ) deposition and hyperphosphorylated tau accumulation. Although several clinical trials have been conducted...